在阳性MRI中加入临床信息能否提高PI-RADS第2版诊断临床显著前列腺癌的准确性
该前瞻性研究纳入137例连续男性共178个可疑病灶,评估PI-RADS v2联合年龄与PSA密度对临床显著前列腺癌(csPCa,Gleason评分>6)的诊断效能。联合模型AUC为0.84,显著优于PI-RADS v2单独的0.76、年龄的0.59和PSA密度的0.67,可避免50%(64/128)不必要活检而仅漏诊4%(2/50)csPCa。
要点
- PI-RADS v2评分越高,csPCa检出率越高(p=0.0044)。
- 联合年龄与PSA密度后AUC达0.84,优于PI-RADS v2单独0.76。
- 联合模型可避免50%(64/128)不必要MRI引导活检,仅漏诊4%(2/50)csPCa。
关键影像表现/征象
- 组织病理学证实178个病灶中93个为前列腺癌(52.2%)。
- 93个前列腺癌病灶中50个为csPCa(Gleason评分>6),占53.8%。
- csPCa与更高PI-RADS v2评分显著相关(p=0.0044)。
诊断标准与关键数值
- csPCa定义为Gleason评分>6。
- PI-RADS v2预测csPCa的AUC为0.76,年龄为0.59,PSA密度为0.67。
- 联合回归模型预测csPCa的AUC为0.84,显著优于各单一参数(p≤0.0009)。
- 逻辑回归中年龄、PSA密度和PI-RADS v2评分独立贡献于csPCa诊断(p分别为7.9×10-7、0.097、0.024)。
临床应用与阅片要点
- 联合年龄与PSA密度可帮助避免约50%(64/128)不必要MRI引导活检,仅漏诊4%(2/50)csPCa。
- PI-RADS v2评分越高,csPCa可能性越大(p=0.0044)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To report prostate cancer (PCa) prevalence in Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) categories and investigate the potential to avoid unnecessary, magnetic resonance imaging (MRI)-guided in-bore biopsies by adding clinical and biochemical patient characteristics.
MATERIALS AND METHODS: The present institutional review board-approved, prospective study on 137 consecutive men with 178 suspicious lesions on 3 T MRI was performed. Routine data collected for each patient included patient characteristics (age, prostate volume), clinical background information (prostate-specific antigen [PSA] levels, PSA density), and PI-RADS v2 scores assigned in a double-reading approach.
RESULTS: Histopathological evaluation revealed a total of 93/178 PCa (52.2%). The mean age was 66.3 years and PSA density was 0.24 ng/ml2 (range, 0.04-0.89 ng/ml). Clinically significant PCa (csPCa, Gleason score >6) was confirmed in 50/93 (53.8%) lesions and was significantly associated with higher PI-RADS v2 scores (p=0.0044). On logistic regression analyses, age, PSA density, and PI-RADS v2 scores contributed independently to the diagnosis of csPCa (p=7.9×10-7, p=0.097, and p=0.024, respectively). The resulting area under the receiver operating characteristic curve (AUC) to predict csPCa was 0.76 for PI-RADS v2, 0.59 for age, and 0.67 for PSA density. The combined regression model yielded an AUC of 0.84 for the diagnosis of csPCa and was significantly superior to each single parameter (p≤0.0009, respectively). Unnecessary biopsies could have been avoided in 50% (64/128) while only 4% (2/50) of csPCa lesions would have been missed.
CONCLUSIONS: Adding age and PSA density to PI-RADS v2 scores improves the diagnostic accuracy for csPCa. A combination of these variables with PI-RADS v2 can help to avoid unnecessary in-bore biopsies while still detecting the majority of csPCa.
引用
- Polanec SH, Bickel H, Wengert GJ, et al. Can the addition of clinical information improve the accuracy of PI-RADS version 2 for the diagnosis of clinically significant prostate cancer in positive MRI? Clin Radiol. 2019. PMID: 31690449. doi:10.1016/j.crad.2019.09.139
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。